These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2546271)

  • 1. Treatment of high grade glioma xenografts with nitrosoureas in nude mice.
    Stuschke M; Bamberg M; Strehl K; Budach W; Sprengel M
    Strahlenther Onkol; 1989 Jul; 165(7):539-40. PubMed ID: 2546271
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneous response to chemotherapy of human gliomas grown in nude mice and as clones in vitro.
    Shapiro WR; Yung WA; Basler GA; Shapiro JR
    Cancer Treat Rep; 1981; 65 Suppl 2():55-9. PubMed ID: 7346147
    [No Abstract]   [Full Text] [Related]  

  • 3. Biology of gliomas: potential clinical implications of glioma cellular heterogeneity.
    Bigner DD
    Neurosurgery; 1981 Sep; 9(3):320-6. PubMed ID: 6272152
    [No Abstract]   [Full Text] [Related]  

  • 4. New xenograft model for assessing experimental therapy of central nervous system tumors: human glioblastoma in the intrathecal compartment of the nude mouse.
    Abernathey CD; Kooistra KL; Wilcox GL; Laws ER
    Neurosurgery; 1988 May; 22(5):877-81. PubMed ID: 2837674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antitumoral action of polyamine linked cyclophosphazenes on human malignant glioma heterografts in nu/nu mice.
    Darcel F; Chatel M; Gautris P; Labarre JF
    Anticancer Res; 1990; 10(6):1563-9. PubMed ID: 2285228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
    Slagel DE; Feola J; Houchens DP; Ovejera AA
    Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
    Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
    Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of five subcutaneous human glioma tumor lines in athymic mice with carmustine, procarbazine, and mithramycin.
    Schold SC; Bigner DD
    Cancer Treat Rep; 1983 Sep; 67(9):811-9. PubMed ID: 6224556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experimental results with the nitrosourea derivative ACNU in the treatment of malignant gliomas.
    Bamberg M; Budach V; Stuschke M; Gerhard L
    Radiother Oncol; 1988 May; 12(1):25-9. PubMed ID: 3165537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor--a new therapeutic approach. Preclinical studies in nude mice.
    Stuben G; Bamberg M; Budach W; Stuschke M; Niederle N
    Strahlenther Onkol; 1989 Jul; 165(7):554-6. PubMed ID: 2546272
    [No Abstract]   [Full Text] [Related]  

  • 11. [Specific curative effects of nitrosourea drugs on tumor cells with Mer--phenotype in Chinese].
    Zhang YP; He T; Chen JM; Chen YN; Xu HY; Fan GC; Wu Y
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):568-71. PubMed ID: 8010061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
    Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
    Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of interleukin II on xenotransplanted grade 3 to 4 glioma in nude mice.
    Weber F; List J; Rommel T; Menzel J; Symas J; Pohl U; Mohr H; Schmitz R; Amue B
    Strahlenther Onkol; 1989 Jul; 165(7):556-8. PubMed ID: 2546273
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL
    Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment with 5-FU, VCR and BCNU in tumor bearing nude mice.
    Köhler L; Schmitz R; Mennigen R; Fuchshuber P; Eypasch E
    Strahlenther Onkol; 1989 Jul; 165(7):542-4. PubMed ID: 2749493
    [No Abstract]   [Full Text] [Related]  

  • 16. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.
    Roth W; Isenmann S; Naumann U; Kügler S; Bähr M; Dichgans J; Ashkenazi A; Weller M
    Biochem Biophys Res Commun; 1999 Nov; 265(2):479-83. PubMed ID: 10558893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.
    Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul M
    Clin Cancer Res; 2001 Mar; 7(3):634-40. PubMed ID: 11297259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
    Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
    Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of nude mice in research on human cancer--screening system of anticancer agents using human tumor xenografts in nude mice.
    Ueyama Y
    Prog Clin Biol Res; 1987; 229():287-310. PubMed ID: 3601990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
    J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.